SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about board meeting intimation

02 May 2022 Evaluate

Ajanta Pharma has informed that pursuant to Regulation 29 of the Listing Regulations, a meeting of the Board of Directors of the Company will be held on Tuesday, 10th May 2022 to consider Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2022; Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2022 and issue of bonus shares subject to approval by the shareholders of the Company.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2790.15 -37.95 (-1.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×